P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
Permanent Carbon Removal, Grid Services and Clean Water Josh Santos, Co-Founder & CEO, Noya Noya: https://www.noya.co/
Noya is working to deliver the high-quality, permanent, carbon removal that the Intergovernmental Panel on Climate Change (IPCC) has identified as necessary in order to limit global warming below 1.5℃. The company’s proprietary direct air capture (DAC) system produces a significant amount of clean water (6 million m3 per year per full-scale facility) and unlocks grid services in addition to high-quality carbon removal credits. The team enjoys strong support from pioneering carbon removal buyers, including Shopify, Watershed, and one of the largest university endowments, as well as leading investors including USV, Collab Fund, EQT, and DNX Ventures.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
David Knezevic, CTO, Akselos
This session is part of MIT Startup Exchange Sales Training, a series of complimentary learning sessions designed for the Exchange’s startups and entrepreneurs.
Activate Customer Data with Decision Intelligence Abhi Yadav, Co-Founder & CEO, iCustomer iCustomer: https://www.icustomer.ai/
GTM teams are overwhelmed by fragmented data across platforms, leading to ineffective targeting, false signals loop, wasted time, and frustrated buyers and sellers. This chaos results in high acquisition costs, bad retention and missed opportunities.
iCustomer's agentic AI platform unifies first-party and third-party customer data to deliver actionable intelligence. The system automates decision-making and orchestrates optimized GTM plays, enabling teams to execute with precision and efficiency.
Our Identity Resolution Engine creates immutable IDs mapped to hundreds of external data sources, while our Decision Intelligence Layer activates optimal GTM plays powered by AI Agents. The platform continuously optimizes CAC, LTV, and Ad ROI through machine learning and real-time market signals.